Mylan News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.08.17	Breakfast Technical Briefing on Generic Drugs Stocks -- Horizon Pharma, Mylan, Neurocrine Biosciences, and Rigel Pharma (PR Newswire)
10.08.17	Mylan Advances Access in the Fight Against HIV with the Launch of Three Generic Antiretroviral Medicines in Canada (PR Newswire)
09.08.17	Mylan Cuts 2017 Outlook; Stock Down (RTTNews)
09.08.17	Mylan N.V. Profit Retreats 0% In Q2 (RTTNews)
09.08.17	Mylan Reports Second Quarter 2017 Results and Updates 2017 Guidance (PR Newswire)
08.08.17	Mylan Pharma Launches Avonza In India (RTTNews)
08.08.17	Mylan Launches Avonza™ in India (PR Newswire)
07.08.17	Mylan Gets FDA's Tentative Approval For "TLD" Under PEPFAR For HIV/AIDS (RTTNews)
26.07.17	Mylan Receives WHO Prequalification for Generic Sovaldi® (PR Newswire)
20.07.17	SRPT Soars On Q2 Results & Outlook, AERI's Mercury-1 Does An Encore, ALIM Abuzz (RTTNews)
19.07.17	Theravance Biopharma and Mylan Announce Positive Results from 12-Month Phase 3 Safety Study of Revefenacin (TD-4208) in Patients with Chronic Obstructive Pulmonary Disease (COPD) (PR Newswire)
19.07.17	Theravance Biopharma and Mylan Announce Positive Results from 12-Month Phase 3 Safety Study of Revefenacin (TD-4208) in Patients with Chronic Obstructive Pulmonary Disease (COPD) (PR Newswire)
19.07.17	Mylan to Report Second Quarter 2017 Financial Results on Aug. 9, 2017 (PR Newswire)
14.07.17	FDA Panel Backs 2 Biosimilars, ALDR Abuzz, MDXG Q2 Revenue Grows 33% (RTTNews)
14.07.17	FDA Panel Recommends Approval Of Mylan And Biocon's Biosimilar Trastuzumab (RTTNews)
13.07.17	FDA Oncologic Drugs Advisory Committee Unanimously Recommends Approval of Mylan and Biocon's Proposed Biosimilar Trastuzumab (PR Newswire)
13.07.17	NVS Gets Thumbs Up, Two Biosimilar Candidates To Face FDA Panel, VKTX On Track (RTTNews)
10.07.17	Technical Snapshots for These Generic Drugs Stocks -- Horizon Pharma, Mylan, Neurocrine Biosciences, and Rigel Pharma (PR Newswire)
29.06.17	Biotech Stocks Facing FDA Decision In July (RTTNews)
21.06.17	Insight - Drugmaker Mylan gets boost from unlikely source: coal (Reuters)
10.06.17	Mylan and Biocon Present Clinical Data on Insulin Glargine at the American Diabetes Association's 77th Scientific Sessions (PR Newswire)
07.06.17	Mylan to Present at Goldman Sachs 38th Annual Global Healthcare Conference (PR Newswire)
02.06.17	Mylan Launches Generic Version Of Teva's Azilect Tablets - Quick Facts (RTTNews)
02.06.17	Mylan Launches Generic Azilect® Tablets (PR Newswire)
02.06.17	Mylan Launches Generic Version Of Novartis' Reclast Injection - Quick Facts (RTTNews)
02.06.17	Mylan Launches Generic Reclast® Injection (PR Newswire)
01.06.17	Senator: Mylan Overcharged Government By $1.2 Bln For Epipen (RTTNews)
30.05.17	Technical Reports on Generic Drugs Stocks -- Mylan, Allergan, Horizon Pharma, and Neurocrine Biosciences (PR Newswire)
23.05.17	Theravance Biopharma and Mylan Report Additional Phase 3 Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS (PR Newswire)
23.05.17	Theravance Biopharma and Mylan Report Additional Phase 3 Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS (PR Newswire)
17.05.17	Theravance Biopharma and Mylan to Present Additional Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS (PR Newswire)
16.05.17	Mylan to Present at UBS Global Healthcare Conference (PR Newswire)
16.05.17	Mylan Honors National Women's Health Week to Empower Women to Take Control of Their Health (PR Newswire)
11.05.17	Citigroup, 21st Century Fox, Mylan, TripAdvisor Inc., and Zayo Group Holdings Inc. and more offer option-trading opportunities that offer returns of more than 18% (PR Newswire)
10.05.17	Mylan N.V. Reports 29% Gain In Q1 Profit (RTTNews)
10.05.17	Mylan Reports First Quarter 2017 Results (PR Newswire)
01.05.17	Mylan Nominates Sjoerd Vollebregt for Election to Board of Directors (PR Newswire)
27.04.17	Mylan to Report First Quarter 2017 Financial Results on May 10, 2017 (PR Newswire)
27.04.17	Technical Reports on Generic Drugs Stocks -- Mylan, Allergan, Horizon Pharma, and Rigel Pharma (PR Newswire)
25.04.17	Autism Awareness Puts Spotlight on Development of Innovative Therapies and Treatments for Youth Mental Disorders (PR Newswire)
25.04.17	Autism Awareness Puts Spotlight on Development of Innovative Therapies and Treatments for Youth Mental Disorders (PR Newswire)
24.04.17	Sanofi Sues Mylan Over EpiPen Marketing (RTTNews)
20.04.17	Mylan Launches Generic Trilafon Tablets (PR Newswire)
03.04.17	Setback For ACOR In Ampyra Suit, EARS Put On Notice, STDY On Steady Rise (RTTNews)
31.03.17	Mylan Provides Update on Meridian Medical Technologies', a Pfizer Company, Expanded Voluntary Worldwide Recall of EpiPen® Auto-Injector (PR Newswire)
30.03.17	FDA Snubs MYL, Roche Wins FDA Panel Vote Hands Down, TNXP Falls After-hours (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

12:26		Verluste in Zürich: SMI verbucht Verluste
12:26		Montagshandel in Europa: STOXX 50 mittags mit Kursplus
12:26		Optimismus in Zürich: Anleger lassen SLI mittags steigen
12:25		Novartis-Aktie fällt: Novartis will bei Krebskongressen zahlreiche Studiendaten präsentieren
10:03		SMI-Wert Novartis-Aktie: So viel Gewinn hätte ein Investment in Novartis von vor einem Jahr eingefahren
09:30		Novartis-Aktie: Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) gibt Hold-Bewertung bekannt
09:28		Gewinne in Zürich: SLI zum Start in Grün
09:28		Freundlicher Handel: SMI bewegt sich zum Handelsstart im Plus

12:26

Verluste in Zürich: SMI verbucht Verluste

12:26

Montagshandel in Europa: STOXX 50 mittags mit Kursplus

12:26

Optimismus in Zürich: Anleger lassen SLI mittags steigen

12:25

Novartis-Aktie fällt: Novartis will bei Krebskongressen zahlreiche Studiendaten präsentieren

10:03

SMI-Wert Novartis-Aktie: So viel Gewinn hätte ein Investment in Novartis von vor einem Jahr eingefahren

09:30

Novartis-Aktie: Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) gibt Hold-Bewertung bekannt

09:28

Gewinne in Zürich: SLI zum Start in Grün

09:28

Freundlicher Handel: SMI bewegt sich zum Handelsstart im Plus

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	121.00	2.07 %	K V
Lonza Grp	528.20	1.30 %	K V
Swiss Re	129.00	0.55 %	K V
Logitech Intl	71.26	0.34 %	K V
Part Grp Hldg	1’265.50	0.16 %	K V
Geberit	522.20	-0.87 %	K V
Givaudan	3’890.00	-1.09 %	K V
Sonova Hldg	307.70	-1.41 %	K V
Swiss Life Hldg	722.60	-1.50 %	K V
Novartis	92.14	-1.64 %	K V

Nachrichten zu Mylan N.V.

Aktien Top/Flop

Mylan Peer Group Nachrichten

Meistgelesene Nachrichten